The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...

A new study published in the Journal of American Medical Association showed that despite partial participant adherence, it ...

Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific differences in gut bacteria. A screening-cohort analysis of microbiome ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The American Cancer Society is adding some new testing options to its screening guidelines for colorectal cancers – and for the first time, that includes a blood test.Colonoscopies are still ...

Fecal immunochemical testing (FIT) is a non-invasive screening modality that quantifies haemoglobin levels in stool to detect occult bleeding from colorectal neoplasia. By offering a simple home-based ...

The FIT test analyzed in the study has patients poke a stool sample with a plastic stick and return it to a lab, which checks ...

There is a saying about fitness that runs along the lines of "the best type of exercise is the one that you will do." Updated colorectal cancer screening guidelines, released by the American Cancer ...

Fecal occult blood testing (FOBT) is a non-invasive screening tool designed to detect hidden blood in stool as an early indicator of colorectal neoplasia. Employed widely in organised screening ...

It can indicate a more advanced stage of the disease or can be a sign of a different medical condition.

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that detects traces of blood in the stool.

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...